Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event

Aims: The J-STARS study examined whether pravastatin (10 mg/day) reduces recurrence of stroke in non-cardioembolic ischemic stroke patients who were enrolled within 1 month to 3 years after initial stroke events (ClinicalTrials.gov, NCT00221104). The main results showed that the frequency of atherot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Atheroscler Thromb
Main Authors: Hosomi, Naohisa, Nagai, Yoji, Kitagawa, Kazuo, Nakagawa, Yoko, Aoki, Shiro, Nezu, Tomohisa, Kagimura, Tatsuo, Maruyama, Hirofumi, Origasa, Hideki, Minematsu, Kazuo, Uchiyama, Shinichiro, Matsumoto, Masayasu
Formato: Artigo
Idioma:Inglês
Publicado em: Japan Atherosclerosis Society 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5868512/
https://ncbi.nlm.nih.gov/pubmed/28924103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.40196
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados